Cannabics Pharma Stock Forecast

Hold candidate since Nov 17, 2025

The Cannabics Pharma stock price gained 33.33% on the last trading day (Monday, 17th Nov 2025), rising from $0.0003 to $0.0004. During the last trading day the stock fluctuated 33.33% from a day low at $0.0003 to a day high of $0.0004. The price has risen in 4 of the last 10 days and is up by 33.33% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $538.90 .

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.0005 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -19.21% during the next 3 months and, with a 90% probability hold a price between $0.0001 and $0.0004 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CNBX Signals & Forecast

The Cannabics Pharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.0003 and $0.0004. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Cannabics Pharma has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, October 17, 2025, and so far it has fallen -20.00%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Cannabics Pharma stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0004 and $0.0003. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cannabics Pharma finds support just below today's level at $0.0004. If this is broken, then the next support from accumulated volume will be at $0.0003 and $0.0003.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0001 between high and low, or 33.33%. For the last week, the stock has had daily average volatility of 10.00%.

Our recommended stop-loss: $0.0004 (-4.22%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 21 days ago.)

Trading Expectations (CNBX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Cannabics Pharma to open at $0.0004, and during the day (based on 14 day Average True Range), to move between $0.0004 and $0.0004, which gives a possible trading interval of +/-$0.00007235589310 (+/-19.89%) up or down from last closing price. If Cannabics Pharma takes out the full calculated possible swing range there will be an estimated 19.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0005 (12.50%) than the support at $0.0004 (12.50%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cannabics Pharma stock A Buy?

Cannabics Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.0004 ( 8.33%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk